Home
Conditions
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

294 public trials 62 recruiting studies

Refine in advanced search Browse all conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma

NCT02652715

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Adult T-Cell Leukemia/Lymphoma, Anaplastic Large Cell Lymphoma, +76 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders

NCT00856388

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436618

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic - Jacksonville Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01529827

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +179 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

NCT02518113

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: City of Hope National Medical Center Duarte, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Karmanos Cancer Institute Detroit, Michigan, United States

Memorial Sloan Kettering Cancer Center New York, United States

View all 22 locations

View Trial Details

Completed

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01839916

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +134 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

NCT01363817

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memorial Sloan Kettering Cancer Center New York, United States

The University Of Texas MD Anderson Cancer Center Houston, Texas, United States

Local Institution Marseille, France

View Trial Details

Completed

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

NCT01164709

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Congenital Abnormalities, +42 more
Locations: Inselspital Bern Bern, Switzerland

Kantonsspital Graubuenden Chur, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

Kantonsspital - St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

NCT00005639

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions